Sling Therapeutics
Manufacturing · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
455 E Eisenhower Pkwy Ste 300 Pmb 109, A...Phone Number
(212) 253-8881Website
www.slingtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sling Therapeutics
Sling Therapeutics is focused on developing new therapies for Thyroid Eye Disease (TED) and beyond, with a mission centered on patient impact and high-quality clinical development. Their pipeline includes Linsitinib, an oral therapy designed to reduce the treatment burden for patients, caregivers, and healthcare providers. The company is supported by an experienced team of executives, drug developers, and scientific advisors dedicated to finding innovative solutions. Target clients include patients suffering from TED, their caregivers, and healthcare professionals involved in their treatment.Explore more
Sling Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sling Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Sling Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sling Therapeutics
Check out if Sling Therapeutics is spiking on competitors!
Product Launch: Get notified when Sling Therapeutics launches new products
Funding: Get notified immidiatlly once Sling Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sling Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Sling Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sling Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Sling Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Sling Therapeutics
Compare insights from companies similar to Sling Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sling Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sling Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sling Therapeutics.
Sling Therapeutics Tech Stack
A closer look at the technologies used by Sling Therapeutics
See more technologies
Sling Therapeutics News & Media
Sling Therapeutics Announces Positive Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease
- Linsitinib is the first and only oral small molecule therapy to establish statistical and clinical significance in Thyroid Eye Disease (TED) - Phase 2b/3 LIDS trial met primary endpoint of proptosis reduction with statistical significance at 150mg BID dose - Linsitinib was...Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference
ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ -- Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused on the development of an oral small molecule for the treatment of thyroid eye disease (TED), will announce topline data from the Phase 2b/3 LIDS trial of linsitinib in...Sling Therapeutics Appoints Andrew Guggenhime to its Board of Directors
ANN ARBOR, Mich., Jan. 7, 2025 /PRNewswire/ -- Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced the appointment of Andrew Guggenhime, an experienced biopharma...Sling Therapeutics Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
ANN ARBOR, Mich., Jan. 6, 2025 /PRNewswire/ -- Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced that Raymond Douglas, M.D., Ph.D., Chief Scientific Officer of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sling Therapeutics
Sign Up For FreeTo access detailed company insights
Sling Therapeutics is focused on developing new therapies for Thyroid Eye Disease (TED) and beyond, with a mission centered on patient impact and high-quality clinical development. Their pipeline includes Linsitinib, an oral therapy designed to reduce the treatment burden for patients, caregivers, and healthcare providers. The company is supported... Read More
